Inventor
MARCUS ANDREW
US16 patents
⚠️ This page may combine multiple inventors who share the name “MARCUS ANDREW”. Patents are grouped by organization below to help distinguish them — per-person disambiguation is on the roadmap.
VITAE PHARMACEUTICALS INC
8 patentsUS9266886B2Feb 23, 2016
Dihydropyrrolopyridine inhibitors of ROR-gamma
VITAE PHARMACEUTICALS INC24 citations94
US10047085B2Aug 14, 2018
Dihydropyrrolopyridine inhibitors of ROR-gamma
VITAE PHARMACEUTICALS INC14 citations92
US9624217B2Apr 18, 2017
Dihydropyrrolopyridine inhibitors of ROR-gamma
VITAE PHARMACEUTICALS INC14 citations92
US10087184B2Oct 2, 2018
Dihydropyrrolopyridine inhibitors of RORγ
VITAE PHARMACEUTICALS INC10 citations84
US9868748B2Jan 16, 2018
Thiazolopyrrolidine inhibitors of ROR- γ
VITAE PHARMACEUTICALS INC13 citations84
US9796710B2Oct 24, 2017
Dihydropyrrolopyridine inhibitors of ROR-gamma
VITAE PHARMACEUTICALS INC12 citations84
US9663515B2May 30, 2017
Dihydropyrrolopyridine inhibitors of ROR-gamma
VITAE PHARMACEUTICALS INC13 citations84
US9845308B2Dec 19, 2017
Isoindoline inhibitors of ROR-gamma
VITAE PHARMACEUTICALS INC2 citations73
VITAE PHARMACEUTICALS LLC
7 patentsUS10399976B2Sep 3, 2019
Dihydropyrrolopyridine inhibitors of ROR-gamma
VITAE PHARMACEUTICALS LLC11 citations92
US10807980B2Oct 20, 2020
Dihydropyrrolopyridine inhibitors of ROR-gamma
VITAE PHARMACEUTICALS LLC4 citations84
US10683302B2Jun 16, 2020
Inhibitors of the menin-MLL interaction
VITAE PHARMACEUTICALS LLC9 citations83
US11535614B2Dec 27, 2022
Dihydropyrrolopyridine inhibitors of ROR-gamma
VITAE PHARMACEUTICALS LLC1 citations73
US11479557B2Oct 25, 2022
Inhibitors of the menin-MLL interaction
VITAE PHARMACEUTICALS LLC4 citations72
US12312359B2May 27, 2025
Inhibitors of the menin-MLL interaction
VITAE PHARMACEUTICALS LLC1 citations63
US11001583B2May 11, 2021
Dihydropyrrolopyridine inhibitors of ROR-gamma
VITAE PHARMACEUTICALS LLC1 citations62